Eton Pharmaceuticals Inc
NASDAQ:ETON
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Eton Pharmaceuticals Inc
NASDAQ:ETON
|
US |
|
Tenaris SA
NYSE:TS
|
LU |
|
S
|
System1 Group PLC
XBER:BBA
|
UK |
|
K
|
Kawasaki Heavy Industries Ltd
XMUN:KHE
|
JP |
|
B
|
Brain+ A/S
CSE:BRAINP
|
DK |
|
C
|
Colabor Group Inc
TSX:GCL
|
CA |
Wall St Price Targets
ETON Price Targets Summary
Eton Pharmaceuticals Inc
According to Wall Street analysts, the average 1-year price target for
ETON is 68.85 USD with a low forecast of 62.62 USD and a high forecast of 73.5 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is ETON's stock price target?
Price Target
68.85
USD
According to Wall Street analysts, the average 1-year price target for
ETON is 68.85 USD with a low forecast of 62.62 USD and a high forecast of 73.5 USD.
What is the Revenue forecast for Eton Pharmaceuticals Inc?
Projected CAGR
33%
The compound annual growth rate for Revenue over the next 8 years is 33%.
What is the Gross Profit forecast for Eton Pharmaceuticals Inc?
Projected CAGR
41%
The compound annual growth rate for Gross Profit over the next 7 years is 41%.